Tsung-Cheng Chang
1PUBLICATIONS
13CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (1)
Sort by Publication Date:
|Mar 14, 2024
PRMT5 is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer.Chang-Ching Lin, Tsung-Cheng Chang, Yunguan Wang
Pageof 1
Frequent Collaborators
1 joint publications
Chang-Ching Lin
1 joint publications
Emmanuel Bikorimana
1 joint publications
Andrew Lemoff
1 joint publications
Kyung-Min Lee
1 joint publications
Joseph J Otto
1 joint publications
Fabiana Napolitano
1 joint publications
Ram Mani
1 joint publications
David W Cescon
1 joint publications
Lin Xu
1 joint publications
Yang Xie
